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Key points
 Early-afterdepolarizations (EADs) are abnormal action potential oscillations and a known
cause of cardiac arrhythmias. Ventricular EADs involve reactivation of a Ca2+ current (ICaL) in
its ‘window region’ voltage range. However, electrical mechanisms of atrial EADs, a potential
cause of atrial fibrillation, are poorly understood.
 Atrial cells were obtained from consenting patients undergoing heart surgery, as well as from
rabbits. ICaL was blocked with nifedipine and then a hybrid patch clamp/mathematical-
modelling technique, ‘dynamic clamping’, was used to record action potentials at the same
time as injecting an artificial, modifiable, ICaL (ICaL,D-C).
 Progressively widening the ICaL,D-C window region produced EADs of various types, dependent
onwindowwidth. EADproductionwas strongest uponmoving the activation (vs. inactivation)
side of the window.
 EADs were then induced by a different method: increasing ICaL,D-C amplitude and/or K+
channel-blockade (4-aminopyridine). Narrowing of the ICaL,D-C window by10mV abolished
these EADs.
 Atrial ICaL window narrowing is worthy of further testing as a potential anti-atrial fibrillation
drug mechanism.
Abstract Atrial early-afterdepolarizations (EADs) may contribute to atrial fibrillation (AF),
perhaps involving reactivation of L-type Ca2+ current (ICaL) in its window region voltage
range. The present study aimed (i) to validate the dynamic clamp technique for modifying
the ICaL contribution to atrial action potential (AP) waveform; (ii) to investigate the effects of
widening the window ICaL on EAD-propensity; and (iii) to test whether EADs from increased
ICaL and AP duration are supressed by narrowing the window ICaL. ICaL and APs were recorded
from rabbit and human atrial myocytes by whole-cell-patch clamp. During AP recording, ICaL
was inhibited (3 µM nifedipine) and replaced by a dynamic clamp model current, ICaL,D-C
(tuned to native ICaL characteristics), computed in real-time (every 50 µs) based on myocyte
membrane potential. ICaL,D-C-injection restored the nifedipine-suppressed AP plateau. Widening
the window ICaL,D-C, symmetrically by stepwise simultaneous equal shifts of half-voltages (V0.5)
of ICaL,D-C activation (negatively) and inactivation (positively), generated EADs (single, multiple
or preceding repolarization failure) in a window width-dependent manner, as well as AP
alternans. A stronger EAD-generating effect resulted from independently shifting activation V0.5
(asymmetrical widening) than inactivation V0.5; for example, a 15 mV activation shift produced
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EADs in nine of 17 (53%) human atrial myocytes vs. 0 of 18 from inactivation shift (P< 0.05). In
11 rabbit atrial myocytes in which EADs were generated either by increasing the conductance of
normalwindowwidth ICaL,D-C or subsequent4-aminopyridine (2mM),window ICaL,D-C narrowing
(10 mV) abolished EADs of all types (P < 0.05). The present study validated the dynamic clamp
for ICaL, which is novel in atrial cardiomyocytes, and showed that EADs of various types are
generated by widening (particularly asymmetrically) the window ICaL, as well as abolished by
narrowing it. Window ICaL narrowing is a potential therapeutic mechanism worth pursuing in
the search for improved anti-AF drugs.
(Received 13 February 2019; accepted after revision 13 May 2019; first published online 15 May 2019)
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Introduction
Afterdepolarizations are premature action potentials (AP)
or subthreshold depolarizations that depend on the pre-
ceding AP for their formation (Fozzard, 1992). Early
afterdepolarizations (EAD) are transient reversals of AP
repolarization that occur either during early (phase 2
EADs) or terminal (late phase 3 EADs) repolarization
(Weiss et al. 2010). EADs can promote arrhythmias by
causing either triggered activity, or electrical heterogeneity
which could predispose to unidirectional conduction
block and reentrant excitation (Wit&Boyden, 2007;Weiss
et al. 2010; Colman et al. 2017), and they are an established
cause of polymorphic ventricular tachycardia in long QT
syndrome (Yan et al. 2001). Evidence is accumulating
that EADs could also be involved in the generation and
maintenance of the most common cardiac arrhythmia:
atrial fibrillation (AF) (Burashnikov &Antzelevitch, 2003;
Wit & Boyden, 2007; Guo et al. 2010; Watanabe et al.
2010; Numata et al. 2012). There is a major unmet clinical
need to develop more effective and safe anti-AF drugs
with novel mechanisms of action (Workman et al. 2011).
Because the suppression of atrial EADs may be a potential
therapeutic target, investigations aimed at improving our
understanding of the electrophysiological mechanisms of
their formation and termination are required.
The dynamic clamp, a powerful hybrid patch
clamp/computationalmodelling technique, is emerging as
a tool ideally suited to such investigations (Wilders, 2006;
Berecki et al. 2014; Ortega et al. 2018). EADs result from a
complex interaction betweenmembrane voltage (Vm), ion
currents, such as L-type Ca2+ (ICaL), Na+/Ca2+-exchanger
(INa/Ca), late Na+ (INaL) and delayed rectifier (IKs, IKr),
and intracellular Ca2+ (Ca2+i)-cycling, although it is
exceedingly difficult to dissect these components and
study them systematically (Weiss et al. 2010; Qu et al.
2013). Regenerative reactivation of ICaL in the ‘window
region’ (where steady-state ICaL activation and inactivation
curves overlap), when AP duration (APD) is sufficiently
prolonged, is considered a prominent EAD mechanism,
as shown in the ventricle (January & Riddle, 1989;
Fozzard, 1992; Weiss et al. 2010; Qu et al. 2013).
Dynamic clamping, by injecting into cardiomyocytes a
mathematically modelled ICaL that changes dynamically
according to Vm, permits the investigation of effects
on APs and EADs of systematically manipulating the
voltage-dependent characteristics of this window current.
Furthermore, because the injected current is not carried
by Ca2+ ions, this provides a unique opportunity to
attempt to separate the electrical effects of ICaL from the
chemical effects of Ca2+ (Berecki et al. 2014). Dynamic
clamping has been used, in rabbit ventricular myocytes,
to show that EADs produced by H2O2 or low [K+]o could
be suppressed purely by the electrical effect of either
shifting ICaL activation or inactivation curves to narrow
the window region (Madhvani et al. 2011), or decreasing a
non-inactivating, pedestal component of ICaL (Madhvani
et al. 2015). Furthermore, a mathematical model of AP
that was optimized after dynamic clamping several ion
currents in guinea-pig ventricular myocytes showed that,
when APD was sufficiently prolonged, an increase in ICaL
conductance could produce EADs suggestive of window
ICaL reactivation (Devenyi et al. 2017).
However, in contrast to ventricle, little is known about
the contribution of window ICaL to EAD formation in
the atrium and, to our knowledge, no study has yet
dynamic clamped ICaL in atrial myocytes from any species.
In rabbit atrial myocytes, we previously observed that
the take-off potential of EADs (produced by decreasing
transient outward K+ current (ITO) in the presence of
β-adrenergic stimulation) was consistently close to the
Vm of the ICaL window centre (Workman et al. 2012). This
suggested that atrial EADs could also involve reactivation
of window ICaL. However, whether the propensity to
EADs, in either rabbit or human atrial myocytes, could
be altered by shifting either ICaL voltage-dependent
activation or inactivation, presently remains unknown.
Such knowledge would advance our mechanistic under-
standing of atrial EAD formation and could have a crucial
bearing on the potential clinical therapeutic utility of
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window ICaL modification in the treatment of AF. Because
the atria of patients with established (chronic) AF have
a shortened APD and reduced ICaL, having undergone
electrical remodelling (Workman et al. 2008; Heijman
et al. 2014), this could limit the therapeutic potential
of window ICaL modification in such patients. However,
such a limitation should not be expected in patients
with non-AF-remodelled atria but who are nevertheless
susceptible to new-onset or paroxysmal AF.
The present study aimed to: (i) validate the dynamic
clamp for simulating, in atrial myocytes from rabbits and
from patients in sinus rhythm, the electrical contribution
of ICaL to APs; (ii) investigate the effects of widening the
ICaL window (symmetrically and asymmetrically) on the
propensity to induce EADs; and (iii) test whether EADs
produced by increasing the ICaL conductance and APD,
could be supressed by narrowing the ICaL window.
Methods
Ethical approval
Procedures and experiments involving human atrial cells
were approved by West of Scotland Research Ethics
Service (REC: 99MC002, 17/WS/0134).Written, informed
consent was obtained from all patients. The investigation
conformed with the principles outlined in theDeclaration
of Helsinki. Procedures and experiments involving rabbit
atrial cells (UK Project Licences: 60/4206, 70/8835)
were approved by Glasgow University Ethics Review
Committee, and conformed with the guidelines from
Directive 2010/63/EU of the European Parliament on
the protection of animals used for scientific purposes.
The investigators understand the ethical principles under
which the Journal of Physiology operates, and our work
complies with the animal ethics checklist in (Grundy,
2015).
Atrial cardiomyocytes
Cardiomyocytes were isolated from rabbit and human
atrial tissues, as described previously (Workman et al.
2000; Workman et al. 2001). Rabbits (New Zealand
White [Envigo, Huntington, UK], male, aged 16–34
weeks, weighing 2.1–3.6 kg, feeding ad libitum; n = 36)
were humanely killed by I.V. injection of anaesthetic
(100 mg kg–1 Na+-pentobarbital, via the left marginal ear
vein) and removal of the heart, which was retrogradely
perfused via the aorta for enzymatic dissociation of
left atrial cells (Workman et al. 2000). Right atrial
tissues were obtained from 28 adult patients (66 ± 2
years; 20 male, eight female) undergoing cardiac surgery
(82% coronary artery bypass graft, 36% aortic valve
replacement). All patients were in sinus rhythm on
the day of surgery. One patient had a history of
paroxysmal AF; none had chronic AF; 75% had
angina, 59% had hypertension, 21% had myocardial
infarction and 15% had diabetes. Left ventricular ejection
fraction was 61 ± 2% (including two patients <45%).
Cardiac drugs: β-blocker (79%), angiotensin-converting
enzyme inhibitor/angiotensin receptor-blocker (39%),
Ca2+ channel-blocker (CCB) (29%), statin (79%), nitrate
(50%), nicorandil (14%) and eplerenone (4%). Cardio-
myocytes were isolated by the ‘chunk’ method (Workman
et al. 2001), stored (9 h, 20 °C) in cardioplaegic
solution (mM): 70 KOH, 40 KCl, 50 L-glutamic acid, 20
taurine, 20 KH2PO4, 3 MgCl2, 10 glucose, 10 Hepes and
0.5 EGTA (pH 7.2).
Whole-cell-patch clamp
Cardiomyocytes were superfused (35–37 °C) with a
physiological salt solution (mM): 140 NaCl, 4 KCl, 1.8
CaCl2, 1 MgCl2, 11 glucose and 10 Hepes (pH 7.4).
Microelectrodes contained (mM): 130 K-aspartate, 15
KCl, 10 NaCl, 1 MgCl2, 10 Hepes and 0.1 K2EGTA
(pH 7.25). The resulting liquid–liquid junction potential
(+9 mV; bath relative to pipette) was compensated for
a priori (Neher, 1992). Microelectrode resistances were
3–6 M. Associated voltage errors during peak ICaL
recording were minimized by bridge-balancing prior
to sealing and expected to be <5 mV; no subsequent
series resistance compensation was applied. Membrane
currents and APs were stimulated and recorded by
whole-cell-patch clamp, with an AxoClamp 2B amplifier
(Axon Instruments, Foster City, CA, USA) and WinWCP
(J. Dempster, University of Strathclyde, Glasgow, UK) or
Clampex (Axon Instruments) software. Ruptured (rather
than perforated) patch configuration was chosen for its
relative ease of controlling access resistance and because
preservation of ICaL-associated intracellular signalling was
not required when dynamic clamping (when ICaL was
necessarily inhibited). ICaL was stimulated with 300 ms
voltage pulses (Fig. 2A). Pulse frequency was 1 Hz, for
best approximation of the influence of Ca2+-induced
inactivation of ICaL in the model ICaL when dynamic
clamping APs at similar rates. Contaminating currents
were suppressed by 4-aminopyridine (4-AP; 5 mM),
niflumic acid (0.1 mM) and TTX (5 µM). APs were
recorded under current clamp in bridge-mode, stimulated
continuously with pulses of 1–2 nA amplitude, 3–5 ms
duration, 0.7-1 Hz frequency, +/– a small holding
current (<1.5 pA pF–1, to gain an initial resting Vm of
-80 mV); parameters were kept constant throughout
protocol. In some myocytes, [Ca2+]i was measured
concurrently with APs by epifluorescence microscopy,
with ratiometric quantification of [Ca2+]i using Fura-2
pentapotassium salt, 0.1 mM (with K2EGTA then lowered
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to 0.01 mM) via the patch pipette. Fluorescence was
measured at 340 and 380 nm every 15 ms using a Cairn
Optoscan monochromator (Cairn Research, Faversham,
UK).Minimum(Rmin) andmaximum(Rmax) fluorescence
ratios (340/380 nm) were measured; cytoplasmic [Ca2+]
was calculated as Kd × [(R – Rmin)/(Rmax – R)], with Kd of
1.2 µM (Kettlewell et al. 2013).
Dynamic clamp technique
The dynamic clamp technique (Fig. 1) was used, during
AP recording in rabbit and human atrial myocytes, to
simulate systematic changes in the voltage-dependent
characteristics of steady-state activation and inactivation
of ICaL. Native ICaL was first inhibited with nifedipine
(3 µM), then replaced by a mathematically modelled,
dynamic clamp current, ICaL,D-C. This current was
computed in real-time, based on the myocyte’s
continuously monitored Vm during the AP, and injected
into the cell via the patch-pipette (by adding it
to the AxoClamp 2B stimulus current pathway) at
precisely-timed 50 µs intervals (update rate: 20 kHz).
Because the ICaL,D-C injection in turn modifies the Vm,
there is a bidirectional dynamic interaction between
the AP waveform and ICaL,D-C (Fig. 1). The ICaL model
implemented in the dynamic clamp is a simplified
version of that developed by Nygren et al. (1998) and
exhibits exponential voltage-dependent activation, as well
as bi-exponential inactivation with a fast component
governed by [Ca2+]i. Equations (1)–(10) (shown in
Fig. 1 in general form, and also below containing values
obtained from the experiments) define ICaL, governed by
a voltage-dependent activation factor (dL ) and exhibiting
a bi-exponential decay (f L 1, f L 2), with semi-empirical,
steady-state activation (d¯L ), inactivation (f¯ L ) and time
constant curves (τd,τfL1,τfL2); all tuned to the voltage- and
time-dependent parameters of the native ICaL (Fig. 2).
In the absence of information on [Ca2+]i accessible
to the dynamic clamp, the Ca2+-dependency of ICaL
inactivation was simplified by fixing fCa (determining
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dt τL1
= dfL2 fL2 – fL2
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=
Figure 1. Dynamic clamp set-up and
method
Personal computer (PC) running standard
electrophysiology software to generate a
train of short pulses (‘a’), which are sent
(Im, stim) to input (Icommand) of a patch clamp
amplifier (PCA) instructing it to inject
current pulses to elicit action potentials (AP)
in an isolated cardiomyocyte (CM). The
membrane voltage (Vm) change is measured
by PCA and sent (Vm, rec) from PCA output
(Vmembrane) for display and recording on the
PC (i.e. conventional AP recording) (‘AP1’).
When the dynamic clamp (D-C)
microcontroller is switched on (‘D-C on’), it
continuously samples Vm (from PCA
Vmembrane) during subsequent AP recording
and, using Hodgkin–Huxley equations (eqns
1-10; definitions in the Methods), calculates
a model L-type Ca2+ current (ICaL) based on
instantaneous Vm, which is updated and
injected, as a dynamic clamp current
(ICaL,D-C), into the stimulus pathway (via
Icommand) at precisely timed 50 µs intervals.
Because ICaL,D-C injection modifies Vm, and
vice versa, there is a bidirectional dynamic
interaction between the waveforms of the
ensuing AP (‘AP2’) and corresponding
ICaL,D-C (‘b’). Parameters in eqns (1)–(10) are
initially set with control values measured in
atrial cells (Fig. 2), then systematically
changed to investigate effects of altering
magnitude, polarity, voltage- and/or
time-dependence of ICaL,D-C (‘+/-/
ICaL,D-C’) on AP2 and subsequent APs.
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relative proportion of fast and slow decay) at 0.5.
The dynamic clamp was custom-built using a National
Instruments CRIO-9076 real time controller, equipped
with a 400 MHz PowerPC CPU, Xilinx Spartan 6 FPGA
(Field Programmable Gate Array) and 16 bit A/D andD/A
converters (National Instruments,Newbury,UK).The ICaL
model, executing on the FPGA, was written in LabVIEW
(National Instruments) and the device controlled from a
host computer via an RS232 interface. The user interface,
for defining and controlling ICaL,D-C characteristics, was
custom written: WinWCP DCLAMP (John Dempster).
By systematically and independently shifting half-voltages
(V0.5) of ICaL,D-C activation and inactivation, via this inter-
face, the effects of changing the ICaL,D-C window region on
AP characteristics including EADs could be investigated.
All effects were checked for reversibility upon removal of
such ICaL,D-C interventions.
ICaL models implemented in the dynamic clamp,
containing values from the experimental data shown
in Fig. 2
Rabbit:
ICa,L = g¯Ca,LdL [f Caf L1 + (1 − f Ca) f L2] (V − 49.5) (1)
dL = 1
1 + e(V+14.6)/4.5 (2)
f¯ L1 = f¯ L2 = 1
1 + e(V+28.3)/4.4 (3)
ddL
dt
= d¯L − dL
τdL
(4)
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b
e
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c
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Figure 2. Comparison of live and
simulated atrial ICaL in rabbit and
human
Circles, rabbit; squares, human. Filled
symbols, live atrial cell data (ICaL); open
symbols, current generated by dynamic
clamp ICaL models (ICaL,D-C). A, voltage
protocols for steady-state activation (Aa)
and inactivation (Ab) of ICaL or ICaL,D-C,
producing currents in (Ba) and (Bb). C,
mean ± SE voltage- and time-dependence
of ICaL activation and inactivation in live
cells (n = 22–35 cells/four rabbits; 13–43
cells/seven patients), or ICaL,D-C from single
simulation runs. Ca, steady-state activation
current density. Cb and Cc, steady-state
activation and inactivation conductance (G).
Cd, activation time constant. Ce and Cf,
fast and slow inactivation time constants.
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df L1
dt
= f¯ L1 − f L1
τL1
(5)
df L2
dt
= f¯ L2 − f L2
τL2
(6)
f Ca =
[
Ca2+
]
i[
Ca2+
]
i
+ kCa
= 0.5 (7)
τdL = 0.0018e−((V+21)/25)2 + 0.0024 (8)
τfL1 = 0.74e−((V+29.6)/5.8)2 + 0.066 (9)
τfL2 = 29.49e−((V−1)/1868)2 + 29.5 (10)
Human:
ICa,L = g¯Ca,LdL [f Caf L1 + (1 − f Ca) f L2] (V − 38.4) (1)
dL = 1
1 + e(V+6.5)/7.8 (2)
f¯ L1 = f¯ L2 = 1
1 + e(V+23)/3.8 (3)
ddL
dt
= d¯L − dL
τdL
(4)
df L1
dt
= f¯ L1 − f L1
τL1
(5)
df L2
dt
= f¯ L2 − f L2
τL2
(6)
f Ca =
[
Ca2+
]
i[
Ca2+
]
i
+ kCa
= 0.5 (7)
τdL = 0.008e−((V+7.5)/52.3)2 + 0.0023 (8)
τfL1 = 6.01e−((V−6.3)/88.3)2 + 6.21 (9)
τfL2 = 0.019e−((V+9.2)/22.6)2 + 0.023 (10)
Strengths and weaknesses of the technique
A significant strength of the dynamic clamp technique is
that, by simulatingmodification of a specific ion current in
a real cell (rather than in a mathematical model), its effect
on the AP waveform can be observed interacting with
all the naturally occurring voltage- and time-dependent
physiological processes, including those not yet discovered
and incorporated into the models. This is not to say that
dynamic clamping is without its own intrinsic limitations,
with the main ones being: (i) Because the modelled ion
channel current is injected through the patchpipette and is
thus carriedprimarilyby ions suchasK+,Cl−, or aspartate,
the ‘chemical effects’ of the specific ion current modelled
(e.g. ICaL), such as local increases in ion concentrations
(e.g. Ca2+) or signalling changes from conformational
changes of the channel, are absent (Berecki et al. 2014).
However, this can also be an opportunity to separate
electrical effects from chemical effects of the current
(Berecki et al. 2014), as in the present study. (ii) The
model current (in this case, ICaL,D-C) is based on voltage-
and time-dependent parameters averaged from recordings
made from multiple cells rather than from the individual
cell being dynamic clamped. (iii) The dynamic clamp
technique naturally shares some of the limitations of
conventional voltage- and current clamp methods, such
as the use of fixed intracellular and extracellular solutions,
and artefacts of electrode resistance and capacitance (Prinz
et al. 2004).
Statistical analysis
Electrophysiological and [Ca2+]i data are expressed as
the mean ± SE. Continuous data were compared,
among three or more groups, using a Friedman repeated
measures test, for non-parametric,matcheddata, followed
by Dunn’s multiple comparisons test. Unpaired data
were compared using a Kruskal–Wallis test, followed
by uncorrected Dunn’s. Categorical data were compared
using a chi-squared test with Yates’ correction. P < 0.05
was considered statistically significant. All statistical and
curve fitting analyses were performed using Prism, version
7.00 (GraphPad Software Inc., San Diego, CA, USA).
Results
Comparison of live and simulated atrial ICaL in rabbit
and human
L-type Ca2+ current (ICaL) showed characteristic rapid,
mono-exponential activation, and slow, bi-exponential
decay, in rabbit and human atrial myocytes (Fig. 2B and
C). Peak ICaL density was 3.9-fold larger in rabbit than
human (Fig. 2Ca), with corresponding Gmax values of
15 nS (0.3 nS pF–1) and 7 nS (0.1 nS pF–1), respectively,
but the voltage-dependence of steady-state activation was
similar (Fig. 2Cb). Other voltage- and time-dependent
ICaL characteristics differed between species, mainly
with human having a positively-shifted steady-state
inactivation compared to rabbit (Fig. 2Cc), and also slower
activation (Fig. 2Cd) and inactivation (Fig. 2Ce and Cf)
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at positive potentials. Dynamic clamp currents (ICaL,D-C),
injected into a simple resistor (500M) capacitor (33 pF)
circuit (Patch-1U model cell; Axon Instruments) and
simulated in response to the same voltage pulse protocols
(Fig. 2Aa and Ab), showed generally close agreement with
the live cell data for all voltage- and time-dependent
parameters (Fig. 2B and C).
Validation of the dynamic clamp technique for ICaL
Native ICaL was substantially inhibited, as shown in
a rabbit atrial myocyte, using nifedipine (Fig. 3Aa).
Nifedipine concentration––response curves (Fig. 3Ab)
indicated complete inhibition of human atrial ICaL (Imax
101%), but only partial inhibition in rabbit (Imax: 87%).
Nifedipine at 3µM, chosenas thehighest concentrationnot
substantially inhibiting currents other than ICaL (e.g. IKur
or ITO) (Gao et al. 2005) was used in both species to allow
dynamic clamp insertion of ICaL,D-C during AP recording.
This inhibited native ICaL by 91% in human and 68% in
rabbit (Fig. 3Ab). In rabbit atrial cells, nifedipine removed
a substantial portion of the AP plateau (Fig. 3Ba), with
a corresponding marked decrease in APD50–90 (Fig. 3Bb),
and also markedly decreased Ca2+ transient amplitude,
CaT (Fig. 3Ca and Cb). Subsequent insertion of ICaL,D-C,
still with nifedipine superfusion, fully restored the plateau
and all but the latest phases of repolarization (APD90)
(Fig. 3Bb), and without further effect on CaT (Fig. 3Ca
andCb).Withoutnifedipine, subtractionof ICaL,D-C,which
offset the electrical (but not [Ca2+]i) effects of ICaL, did
not alter [Ca2+]i (Fig. 3Ca and Cb) and produced similar
APD50-70 changes as nifedipine, although it left a clear
residual ‘AP foot’ (prolonged APD80-90 in Fig. 3Ba and
Bb).
Mathematical modelling of the contribution to AP of
electrical vs. Ca2+ changes from ICaL
The relative contributions of purely electrical (ICaL,D-C)
vs. ‘chemical’ (Ca2+) effects of ICaL-reduction, as well as
the likely cause of the ‘AP foot’ in the above (ICaL,D-C sub-
tractionwithoutnifedipine) experiment,were investigated
using three published mathematical models of human
atrial APs: ‘CRN’ (Courtemanche et al. 1998), ‘Grandi’
(Grandi et al. 2011) and ‘Nygren’(Nygren et al. 1998)
(Fig. 4). In each model, abolition of ICaL (and thus
Ca2+-induced Ca2+-release, CICR) abolished both the AP
plateau (panels Aa, Ba and Ca) and inward INa/Ca (panels
Ab, Bb and Cb). However, compared to ICaL,D-C-abolition
in the presence of full [Ca2+]i-buffering (also abolishing
CICR and inward INa/Ca), ICaL,D-C-abolition alone only
suppressed the plateau, with the difference (i.e. between
dotted and dashed line pairs) being a result of inward
INa/Ca. Qualitatively similar effects of 70% ICaL- or
ICaL,D-C-reduction on APs (panels Ac, Bc and Cc) and
INa/Ca (panels Ad, Bd and Cd) were observed, although
generally attenuated compared to the 100% reductions,
with ‘Grandi’ best qualitatively simulating (Fig. 4Bc) the
‘AP foot’ seen in rabbit atrial cells, accompanied by a
relatively large inward INa/Ca.
Effects of dynamic clamp-widening of the ICaL
window region on atrial AP waveforms
The overlapping region of the respective activation and
inactivation curves ‘N’ in Fig. 5A (taken from Fig. 2Cb
and Cc) signifies the normal ICaL,D-C window region. This
is the Vm range within which a fraction of the current
not inactivated may be available for reactivation. During
continuous AP recording, insertion of normal-window
ICaL,D-C resulted in a normal AP waveform (‘N’) in each
of six rabbit and six human atrial myocytes (Fig. 5Ba
and Bb, upper), with the corresponding ICaL,D-C ‘N’
shown beneath. Note that ICaL,D-C has opposite polarity to
conventionally recorded ICaL because it is injected into the
cell. However, when the window region was progressively
widened, in small (1 mV) steps, by simultaneously and
equally (i.e. symmetrically) shifting half-voltages (V0.5)
of activation and inactivation (Fig. 5A), a variety of
changes inAPwaveformswas observed. In all 12myocytes,
initial window widening increased APD, accompanied
by slowing of ICaL,D-C decay. As the window width was
increased further, EADs were produced, either singly or
with one or more subsequent oscillations, accompanied
by ICaL,D-C reactivation (Fig. 5B). The take-off Vm of
each single (or 1st-of-a-train) EAD ranged −22 mV to
−16mV in rabbit and−44mV to−21mV in human. The
maximumVm of this EADor any subsequent oscillation(s)
was −5 mV in rabbit and −8 mV in human; minimum
Vm of any subsequent oscillation(s): −22 mV in rabbit,
−28mV inhuman. Themaximumrate of rise of eachEAD
upstroke coincided with the peak of the corresponding
reactivating current (ICaL,D-C) and conductance (GCaL,D-C)
(Fig. 5C). In one of the rabbit atrial myocytes (Fig. 5Ba),
initial window widening produced exclusively EADs that
were followed by full repolarization (i.e. conventional
EADs) then, with further widening, exclusively EADs on
APs failing to repolarize (within BCL). In two of the
rabbit myocytes, both EAD types were observed at same
window widths, as it was progressively widened, and, in
the other three, only EADs preceding non-repolarization
occurred. Of the six human atrial myocytes, two showed
a progressive shift from predominantly conventional
EADs to predominantly EADs with non-repolarization
(Fig. 5Bb), with four showing exclusively EADs with
non-repolarization. All effects of window widening were
reversed upon returning to normal-windowwidth ICaL,D-C
at the end of each protocol. Simulation of stepwise
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Figure 3. Validation of dynamic clamp technique for ICaL in rabbit atrial cells
Grey symbols = nifedipine (Nif) present; black = Nif absent. Aa, original current traces showing typical maximal
ICaL-decrease by Nif (3 µM) in a rabbit atrial cell.Ab, Nif-ICaL concentration–response curve for rabbit cells (n= 5–14,
3 or 4 rabbits; circles); with human cells (n = 10–22 cells/3 patients; squares) for comparison. Ba, representative
superimposed APs from a single atrial cell before ( ) and after ( ) 3 µM Nif, during insertion of ICaL,D-C (Gmax
15 nS) in the continued presence of Nif ( ), and during subtraction of ICaL,D-C (Gmax –15 nS) in the absence of Nif
( ). Bb, average AP duration (APD) in 19–22 cells/8 or 9 rabbits under the same conditions as (Ba). Ca, [Ca2+]i
transients (CaT) measured during AP recording under the same conditions as (B). Cb, average [Ca2+]i in 17 cells/6
rabbits from (Bb). ∗P < 0.05 vs. controls, or between groups under lines; NS, not significant; Friedman & Dunn’s
multiple comparisons tests.
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Figure 4. Mathematical modelling of the
contribution to the AP waveform of
electrical and Ca2+ changes from ICaL
decrease, and the involvement of INa/Ca
Action potentials (AP) and Na+/Ca2+-
exchange currents (INa/Ca) simulated using
mathematical models CRN (Courtemanche
et al. 1998) (A), Grandi (Grandi et al. 2011) (B)
and Nygren (Nygren et al. 1998) (C). Aa, Ab,
Ba, Bb, Ca and Cb, superimposed APs and
INa/Ca, respectively (1 Hz stimulation), under a
100% reduction in ICaL or dynamic clamp ICaL
(ICaL,D-C). Ac, Ad, Bc, Bd, Cc and Cd are APs
and INa/Ca under a 70% reduction in ICaL or
ICaL,D-C. Solid black lines indicate the control;
solid grey lines indicate ICaL reduction (e.g. as
from nifedipine); dashed black lines indicate
ICaL,D-C reduction (i.e. isolated electrical
component of ICaL reduction); dotted black
lines indicate ICaL,D-C reduction of 100% (Aa,
Ab, Ba, Bb, Ca and Cb) or 70% (Ac, Ad, Bc,
Bd, Cc and Cd) when holding [Ca2+]i at its
diastolic level (100% Ca2+ buffering).
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widening of the ICaL window, using ‘CRN’ (Courtemanche
et al. 1998), also produced progressive APD-increase,
conventional EADs and, finally, repolarization failure
(Fig. 5D). A further observation in the live cells, albeit
uncommon, was a consistently repeating bi-alternation
of AP-waveform: alternans (Fig. 5E). This occurred in
three of 22 rabbit and two of 31 human atrial cells
(includes cells from Fig. 6E and F), and featured both
maximum diastolic potential (MDP)-alternans (Fig. 5Ea)
and true APD-alternans (i.e. with no accompanying
MDP-alternans) (Fig. 5Eb and Ec).
ICaL,D-C window width-dependence of EAD incidence
in rabbit and human atrium
A systematic study of the effect of symmetrical widening
of the ICaL,D-C window (Fig. 6A) on the incidence of
the two different EAD types (as defined in Fig. 6Ba
and Bb) showed a window width-dependence of EAD
production in rabbit and human atrial myocytes. Note
that the AP response-type in Fig. 6Bc displayed no EAD
and so was not included in the analyses. Representative
traces in Fig. 6C (rabbit) and D (human) illustrate the
respective average data (Fig. 6E and F), showing that, after
insertion of normal-window width ICaL,D-C to recover the
AP plateau pre-supressed by nifedipine (Fig. 6Ea and Fa),
increasing thewindowwidth (in 5mVsteps up to 15mV in
rabbit, 30mV in human) produced a significant, stepwise,
increase in the incidenceof combined-typeEADs (Fig. 6Ec:
rabbit; Fig. 6Fc: human), with no significant effect on the
incidence of solely conventional EADs (Fig. 6Eb and Fb).
Asymmetrical widening of the ICaL,D-C window
produced EADs, particularly when shifting activation
voltage
Widening ICaL,D-C window asymmetrically, by shifting
independently (solely) either the activation or inactivation
curves (e.g Fig. 7A for rabbit; Fig. 7B for human),
also produced EADs, although preferentially from
shifting activation. In rabbit, significant production of
conventional EADs resulted from a 10 mV shift of either
curve (Fig. 7Ca and Eb). Considering combined-type
EADs (Fig. 7Ca and Cb), a significantly higher incidence
resulted from negatively-shifting the activation curve
compared to positively-shifting inactivation (Fig. 7Ec).
Such a differential effect of activation vs. inactivation
curve-shifting was also significant in human (Fig. 7Da,
Db and Fc), and more pronounced than in rabbit, with
no EADs resulting from a 15 mV shift in inactivation, yet
with a 53% EAD incidence in response to an activation
voltage-shift of same magnitude (Fig. 7Fc).
Narrowing the ICaL,D-C window abolished EADs
evoked by increasing current conductance with or
without 4-AP
In rabbit atrial myocytes (n = 18), increasing (by
three-fold) the maximum conductance (Gmax) of
normal-window width ICaL,D-C, which left the window
region configuration entirely unaffected (Fig. 8Aa),
produced EADs in six myocytes, with conventional-type
in four, including multiple EADs (Fig. 8Ba). The
time scale-expanded traces of Fig. 8D shows these Vm
oscillations and associated ICaL,D-C reactivations, along
with the same temporal relationship between peak ICaL,D-C
and EAD upstroke as observed in the earlier (Fig. 5C)
window widening experiments. In every cell, narrowing
of the ICaL,D-C window (still at three-fold Gmax) by 10 mV,
by simultaneously and equally shifting V0.5 activation
(positively) and inactivation (negatively) (Fig. 8Ab),
abolished all EADs of any type (Fig. 8B and E). This effect
was at least partially reversible (e.g. Fig. 8B). In 10 of the
12 cells in which increasing ICaL,D-C alone did not produce
EADs, 4-AP was subsequently superfused, which, in turn,
produced EADs (Fig. 8C) in five cells. In each of those, the
same window narrowing intervention, in the continued
presence of increased ICaL,D-C+4-AP, also abolished all
EADs of any type (Fig. 8C and F). Combining the data
(n = 11 myocytes) from either intervention affirmed the
Figure 5. Effects of dynamic clamp-widening of the ICaL window on APs in rabbit and human
A, ICaL,D-C-voltage curves used to progressively widen window region during recording of APs (B) by simultaneous
stepwise shifting of half-voltages (V0.5) of activation (negatively) and inactivation (positively) from normal (N), in
rabbit (Aa) (widening by 5–9 mV in 1 mV steps, by 0.5 mV shifting of activation and inactivation) and human (Ab)
(2–14 mV in 2 mV steps). B, superimposed APs (upper) and ICaL,D-C (lower) from a single rabbit (Ba) and human
(Bb) atrial cell, recorded first with 3 µM nifedipine (Nif), then after inserting ICaL,D-C (N), followed by window
widening by arrowed values (mV). AP responses to widening include EADs, and instances of non-repolarization;
ICaL,D-C responses: associated reactivations, and non-inactivations. All traces at same scale (bars = 50 ms, 25 mV).
Grey bands = window voltage ranges, as determined from (Aa) and (Ab), producing EADs. ICaL,D-C bar = 0.2 nA
for (Ba), 0.1 nA for (Bb). C, temporal relationship of changes in Vm (top trace; from Ba, 8 mV widening), its first
derivative (Vm/t), and D-C current (ICaL,D-C) and conductance (GCaL,D-C). D, mathematical simulation, using
CRN (Courtemanche et al. 1998), of AP responses to widening ICaL window by 5, 10 and 15 mV beyond N,
showing production of APD-increase, EAD and non-repolarizing AP. E, sets of eight superimposed consecutive AP
recordings (r: 1–8; black trace = odd r number, grey = even) from rabbit (Ea and Eb) and human (Ec), showing
bi-alternation of MDP (Ea) or APD (Eb and Ec) after 10 mV window widening. Bars = 100 ms, 25 mV.
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Figure 6. Symmetrical widening of the ICaL,D-C window produces EADs in rabbit and human atrial cells
A, ICaL,D-C-voltage curves to widen window region during AP recording; in this case by 10 mV, in rabbit atrial,
by simultaneously shifting activation V0.5 –ve by 5 mV (vs. normal, N) and inactivation V0.5 +ve 5 mV. B,
EAD categorization for (C) to (F). Ba, EADconv = conventional EAD: clear transient depolarization in AP phase
2–3 followed by normal repolarization; Bb, EADN-R = EAD followed by non-repolarizing (within BCL) AP; Bc,
APN-R = non-repolarizing AP without EAD. = EAD. ↓ = ICaL,DC reactivation. All traces (rabbit, 10 mV widening)
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marked anti-EAD effect of narrowing the ICaL,D-C window
region (Fig. 8G).
Discussion
We validated the dynamic clamp technique for
investigating, for the first time to our knowledge,
the electrical contribution of ICaL to atrial APs, and
then made the following key findings: widening the
‘window’ ICaL region, particularly asymmetrically by
shifting voltage-dependent ICaL activation, produced
EADs in a window width-dependent manner in rabbit
and human atrial myocytes, with some instances of
AP-alternans; and narrowing the ICaL window abolished
EADs that were produced by increasing ICaL conductance
and APD.
By informing and tuning the mathematical models
of ICaL used for dynamically injecting ICaL,D-C, with the
steady-state voltage- and time-dependent parameters of
native ICaL measured in the same cell types and under
the same conditions as for dynamic clamping APs, this
ensured an accurate and realistic representation of the
native ICaL during dynamic clamping APs. Some studies
have used action potential clamping as a refinement of
this step (e.g. for ventricular IKr) (Altomare et al. 2015).
Because native ICaL must be pharmacologically inhibited
in order to replace it with ICaL,D-C for systematic study of
manipulating the ICaL,D-C window and, because dynamic
clamp cannot inject Ca2+, there is no Ca2+-induced Ca2+
release (CICR) during each AP. Therefore, a generalized
(fixed) influence of Ca2+-dependent inactivation of ICaL
(CDI) was included in ICaL,D-C, by recording native ICaL
with minimal [Ca2+]i-buffering (low [EGTA] to buffer
reagent-contaminating Ca2+ to physiological diastolic
[Ca2+]i) (Fig. 3C) to permit the CaT during the initial
voltage clamp experiments to affect the ICaL waveform
used to inform the model. ICaL,D-C did not, therefore,
include a dynamically changing CDI. Other approaches
to addressing CDI and absence of CICR when dynamic
clamping have been to model subcellular [Ca2+] changes
and feed back the influence of modelled CDI on the
injected ICaL,D-C (Madhvani et al. 2011; Madhvani et al.
2015). Another consequence of CICR on the AP, INa/Ca,
has not been injected along with ICaL,D-C in any study to
date. We inhibited native ICaL using the best available CCB
at the highest concentration possible without inhibiting
important atrial repolarizing currents such as IKur and
ITO (i.e. nifedipine at 3 µM) (Gotoh et al. 1991; Gao
et al. 2004; Gao et al. 2005). Whilst this substantially
reduced ICaL and CaT, it left a residual30% ICaL in rabbit
atrial cells and10% in human, which could be expected
to produce a resulting component INa/Ca. Nevertheless,
following nifedipine application in rabbit atrial myocytes,
which substantially suppressed AP plateau and shortened
APD, we found that ICaL,D-C-insertion completely restored
AP plateau and all but the latest phases of repolarization,
thus validating ICaL,D-C for studying AP plateau and
EADs. A recent simulation of ‘chemical’ vs. ‘electrical’
effects of INa/Ca-change on guinea-pig ventricular APs
also suggests only a small contribution from INa/Ca to late
repolarization (Devenyi et al. 2017), although atrial APs
were not studied. Conversely, in the present experiments,
subtracting ICaL,D-C in the absence of nifedipine produced
a residual ‘AP-foot’, suggestive of inward INa/Ca under
such a condition. Our mathematical modelling (with
three AP models) (Courtemanche et al. 1998; Nygren
et al. 1998; Grandi et al. 2011) of simultaneous APs and
INa/Ca, with and without full [Ca2+]i-buffering, supported
[Ca2+]i-induced INa/Ca as the cause of this AP-foot
under ICaL,D-C subtraction. Dynamic clamp-subtraction
of ion currents has been used previously to attempt to
overcome non-specificity of a pharmacological blocker
(Workman et al. 2012) or to convert between AP wave-
form types (e.g. changing a mouse ventricular AP to a
more human-like one using a calculated compensatory
current) (Ahrens-Nicklas & Christini, 2009). Whilst
dynamic clamp-subtraction of a suitable compensatory
current (taking into account ICaL and perhaps also INa/Ca)
could be conceived as an alternative to using nifedipine
(before superimposing additional ICaL conductances with
altered window characteristics), implementation and
interpretation would be highly challenging and it was not
attempted in the present study.
A variety of AP, EAD, alternans, and ICaL,D-C responses
resulted from widening ICaL,D-C window; each consistent
with a major contribution from window ICaL,D-C
reactivation. The EADs were always accompanied by
ICaL,D-C-reactivation, and the coincidence of the ICaL,D-C
and GCaL,D-C peak with the EAD upstroke maximum rate
of rise is consistent with ICaL,D-C driving the EAD. The
at same scale: bar on AP = 25 mV; ICaL,D-C = 0.2 nA; time = 100 ms. APs (upper) and ICaL,D-C (lower) from (C)
rabbit and (D) human, with 3 µM Nif ( ), insertion of ICaL,D-C with normal-window ( ), 10 mV widening ( ),
showing production of EADconv (Ca and Da) and EADN-R (Cb and Db). Bars = 50 mV for APs; 0.2 nA for rabbit
ICaL,D-C, 0.1 nA for human; 100 ms for rabbit; 200 ms for human. Grey bands = window voltage ranges, from
ICaL,D-C-voltage curves, producing EADs. Average AP and EAD from rabbit (E) and human (F). Ea and Fa, APD70
(for APs without EADs) in control (Con), following Nif, then ICaL,D-C-insertion (Ins) and 5 mV widening; n = 12
cells/6 rabbits, 11 cells/8 patients. Incidences of cells displaying EADconv (Eb and Fb) or EADconv/EADN-R (Ec and
Fc) after ICaL,D-C-insertion and progressive window widening (5–15 mV in rabbit; 5-30 mV human). Values within
bars: cell n (3–6 rabbits/4–8 patients). P: compares groups under horizontal lines, or vs. ‘Ins’. Friedmans, Dunn’s
multiple comparisons, chi-squared tests.
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Figure 7. Asymmetrical widening of ICaL,D-C window, particularly by shifting activation voltage,
produces EADs
ICaL,D-C-voltage curves used for rabbit (A) and human (B), showing V0.5 shifts of (Aa and Ba) activation and
(Ab and Bb) inactivation (5 mV steps vs. N) to asymmetrically widen the ICaL,D-C-window during AP recording.
APs (upper) and ICaL,D-C (lower) from (C) rabbit and (D) human, with 3 µM Nif ( ), insertion of ICaL,D-C with
normal-window ( ) then –10 mV activation shift ( ), showing EADconv (Ca and Da) and EADN-R (Cb and Db).
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two main conditions for EAD production by window
ICaL reactivation (January & Riddle, 1989; Fozzard, 1992)
were met, namely APD-increase (allowing ICaL,D-C to
dwell in the window region long enough to reactivate)
and the EADs oscillating within a voltage range allowing
ICaL,D-C-activation. For a contribution to these EADs from
any inward INa/Ca (from any residual CICR), EAD take-off
potential would need to be negative to ENa/Ca, which is
expected to be positive to  −30 to −35 mV (Bers,
2002). Because the EADs in rabbit atrial myocytes (in
which any residual CICR would be the larger) arose from
potentials positive to ENa/Ca, this suggests they were caused
mainly or solely by window ICaL,D-C reactivation. Some
of the human atrial EADs arose from potentials negative
to ENa/Ca, and so a potential contribution from inward
INa/Ca to their upstroke cannot be excluded. However, any
such contribution may be expected to be relatively small
because native ICaL was >90% inhibited. Furthermore,
because INa/Ca decreases with depolarization, it cannot
act regeneratively to enhance EAD amplitude unless
[Ca2+]i increases to maintain its driving force (Qu et al.
2013); unlike ICaL, which increases with depolarization
up to 0 or +10 mV and reactivates regeneratively.
Whether or not there was a contribution from INa/Ca,
it is clear that the electrical effect alone of widening
the ICaL window was sufficient, if not necessary, to
generate EADs. These EADs were produced, in rabbit
and human atrial myocytes, by symmetrical widening
ICaL window by simultaneously and equally shifting V0.5
of activation (negatively) and inactivation (positively).
However, we found a strong EAD-generating effect also
resulted from shifting activation V0.5 alone (i.e. with
asymmetrical-widening). Because this effect was stronger
than with shifting inactivation V0.5 alone, it suggests that
the ability of a reactivating ICaL to generate EADs is more
dependent on a larger ICaL arising from more negative
potentials (in line with holding potential-dependence
of ICaL) (Li & Nattel, 1997) than on a relatively small
ICaL-increase permissible from shifting the inactivation
curve towards values around the peak for ICaL (0 or
+10 mV).
Each of the responses to window widening, whether
a single EAD or multiple EAD oscillations followed
by normal repolarization, a single EAD or multiple
EADs followed by repolarization failure, or indeed
repolarization failure with no EAD but rather a
non-oscillating voltage signal (typically at Vm of the ICaL
window centre), can be considered in terms of a ‘Hopf
bifurcation’ model of EADs (Qu et al. 2013). This model
features analogous oscillations and ‘basin of attraction’
equilibrium states, including repolarization failure and
‘bi-stable’ states ofMDP-alternans. Themodel emphasizes
the major influence of ICaL in non-linear dynamical
processes necessary for EADs. It also highlights, however,
the necessity of highly complex interactions between
numerous ion currents and their gating variables for EADs
to occur. This re-enforces the utility of dynamic clamping
for studying EAD mechanisms because such complex
interactions, and those not yet discovered, occur physio-
logically in the myocyte.
Cardiomyocytes require isolation for measuring ion
currents or dynamic clamping APs, but this removes
the syncytial current sink that occurs in vivo. This sink
should be expected to overcome the repolarization failure
observed to follow many of the cellular EADs here, and
also perhaps to dampen the EADs themselves. However,
the inward current producing these cellular events would
still influence net source-to-sink ratio in the direction of
APD-increase and EAD-generation. Whether that could
contribute to arrhythmias in tissues is under debate.
Weiss et al. (2010) propose that, although thousands
of adjacent cells need synchronized EADs to produce a
threshold propagating premature AP, this synchronization
can occur naturally from the interaction between the
divergent influence of chaos driving irregular EADs and
the convergent influence of electrotonic coupling via gap
junctions. Synchronization of chaotic EADs could also
amplify APD-dispersion, forming ‘EAD islands’ next to
regionswithout EADs, creating unidirectional conduction
block and reentry. This self-organizing system could
simultaneously create trigger and substrate for reentry
even when the tissue is homogeneous, although they
would develop more rapidly in heterogeneous tissue
(e.g. fibrosed, aged atrium). Coupling between myo-
cytes and myofibroblasts could also aid EAD production,
demonstrated by dynamic clamping rabbit ventricular
myocytes with an analogous virtual gap junction current
(Nguyen et al. 2012).
To test whether ICaL,D-C window narrowing could
suppress or prevent EADs, we induced EADs either by
increasing the conductance of an injected ICaL,D-C having a
normal window (as produced, for example, by adrenergic
stimulation) (Workman, 2010) or, in myocytes then
failing to generate EADs, adding the APD-prolonging
Bars (all traces) = 50 mV, 0.1 nA, 100 ms. Grey bands = window voltage ranges, as determined from (A) and (B),
producing EADs. Average AP and EAD from rabbit (E) and human (F). Ea and Fa, APD70 in control (Con), following
Nif, ICaL,D-C-insertion (Ins) and a subsequent +5 mV shift in V0.5 inactivation or, separately, a –5 mV activation
shift (n=26 cells/9 rabbits, 11–28 cells/4–10 patients; Friedman or Kruskal–Wallis, Dunn’s tests). Incidences of
cells displaying EADconv (Eb and Fb) or EADconv/EADN-R (Ec and Fc) after ICaL,D-C-insertion and subsequent
act/inactivation V0.5 shifting (5 mV steps). n = 9 or 10 rabbits/4–10 patients. P: compares groups under lines, or vs.
Ins.
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Figure 8. Narrowing ICaL,D-C window abolishes EADs from increased ICaL,D-C and/or 4-AP in rabbit
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influence of K+ current-block from 4-AP (Workman
et al. 2000). These interventions should promote EADs by
increasing reactivating current amplitude and dwell-time,
respectively (January & Riddle, 1989; Fozzard, 1992;
Devenyi et al. 2017). The ICaL,D-C window narrowing
intervention then applied, comprising a simultaneous
equal shift of V0.5 of ICaL,D-C activation (positively)
and inactivation (negatively), favoured shifting activation
over inactivation in the window region itself, resulting
in a rather asymmetrical window narrowing. This
abolished all EADs, whether single, multiple, or preceding
repolarization failure, presumably by affecting the portion
of the window region (the left -activation -limb) shown
above to bemost sensitive for EADproduction; preventing
ICaL reactivation. Although window ICaL characteristics
are determined partly by parameters additional to V0.5
of activation and inactivation curves, previous studies
(Madhvani et al. 2011; Madhvani et al. 2015) on EADs
in rabbit ventricle support the view that it is the altering of
these V0.5 values, rather than the slopes of these curves or
the kinetics of current activation or decay, which suppress
EADs. EADsuppression fromdynamic clamp reductionof
a non-inactivating ‘pedestal’ ICaL (increased by H2O2) was
also shown (Madhvani et al. 2015), which is a component
of ICaL that we did not detect or model in atrial myocytes.
Pathological changes to window ICaL have been
reported, in the ventricle. In dogs, chronic atrioventricular
block-induced hypertrophy was associated with window
ICaL-widening and EADs under β-adrenergic stimulation
(Antoons et al. 2007). A genetic mutation in a patient
with Timothy syndrome, a rare multigenetic disorder
including QT-prolongation, may also cause window
ICaL-widening, APD-increase and EADs (Boczek et al.
2015). In atrium, although ICaL is markedly altered
in terms of peak current density (reduced) and open
probability (increased) in human chronic AF (i.e. electro-
physiological remodelling) (Klein et al. 2003; Workman
et al. 2008; Heijman et al. 2014), there are no reports, to
our knowledge, of pathological changes in window ICaL
voltage-dependence. Enhancement of atrial window ICaL
(e.g. from a pathological widening of the window region
and/or an increase in ICaL preferentially in the window
region) is unlikely to be a mechanism contributing to
EAD production in clinical AF. However, it should be
recognized that a therapeutically effective anti-AF target
does not require to be one that is pathologically altered,
as evidenced by the two most effective anti-AF drugs
(amiodarone and flecainide), which are not considered to
be effective by opposing the most prominent pathological
ion current alterations (namely decreased ICaL and ITO,
and increased IK1) (Workman et al. 2011). Furthermore, a
drug may be (and may be intended to be) more effective
in un-remodelled atrium (as investigated in the present
study); for example, in the treatment of new-onset or
paroxysmal AF.
We propose that narrowing of a non-enhanced (and
non-remodelled) ICaL window may be considered as a
potential therapeutic mechanism to inhibit atrial EADs
caused by any primary mechanism, because of the
likely prominent contribution ultimately (secondarily) of
window ICaL reactivation to such EADs. For example, ICaL
reactivationcouldoccurwitha sufficiently large increase in
AP plateau duration, such as could result from adrenergic
stimulation of ICaL (Workman, 2010) (hence the present
investigation of increasing ICaL,D-C), K+ current reduction
or inhibition (Workman et al. 2001) (hence our use of
4-AP) or early (2–3 weeks) heart failure (Stambler et al.
2003; Yeh et al. 2008), all of which have potential relevance
to AF. However, it must be recognized that dynamic
clamping can assess only electrical (i.e. in the absence of
CICR) effects of changing the current, and this is true for
increasing ICaL,D-C conductance toprovokeEADs, aswell as
for narrowing window ICaL to prevent EADs. Alternatives
to increasing ICaL,D-C could be considered in future studies,
such as oxidative stress (Sato et al. 2009; Madhvani et al.
2011; Zhao et al. 2012; Madhvani et al. 2015) or hypo-
kalaemia (Madhvani et al. 2011; Madhvani et al. 2015), as
used previously in the ventricle.
The potential clinical therapeutic utility of window ICaL
narrowing is supported by recent reviews (Karagueuzian
et al. 2017; Ortega et al. 2018) and based on the
expectation (from modelling: Madhvani et al. 2011;
Madhvani et al. 2015; Karagueuzian et al. 2017) that
this intervention is unlikely to substantially affect [Ca2+]i
A, ICaL,D-C-voltage curves to narrow window region during AP recording. Aa, activation/inactivation curves, of
normal window width, from either 1 × ICaL,D-C Gmax: 15 nS ( ) or 3 × Gmax: 45 nS ( ); window unaltered by the
Gmax-increase. Ab, comparison of the normal-width 45 nS curves ( ) vs. 45 nS curves with window narrowed by
simultaneously shifting V0.5act +5 mV and V0.5inact -5 mV ( ). B and C, APs (upper) and ICaL,D-C (lower), all with
Nif to supress ICaL. 15 nS ICaL,D-C with normal-window ( ), then EADconv (Ba and Ca) or EADN-R (Bb and Cb) were
evoked, either by trebling ICaL,D-C (B) or, in different cells, by trebling ICaL,D-C and adding 4-aminopyridine (4-AP;
2 mM) (C) ( ). Then, the ICaL,D-C window was narrowed ( ), still with Gmax 45 nS (and 4-AP if applicable). Finally,
window narrowing was reversed ( ). Bars = 50 mV, 0.1 nA, 100 ms. Grey bands = window voltage ranges,
as determined from (Aa), producing EADs. D, timescale expansion of traces from (Ba), showing ICaL,D-C–Vm
temporal relationship during EAD-formation. E–G, effect of window narrowing (and its reversal) on incidences
of cells displaying EADconv (Ea, Fa and Ga), or EADconv/EADN-R (Eb, Fb and Gb), evoked by 3 × ICaL,D-C (E) or, in
different cells, 3 × ICaL,D-C + 4-AP (F), or either intervention (G). n = 2 rabbits in (E), n = 3 rabbits in (F), n = 5
rabbits in (G).
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and thus excitation-contraction coupling. By contrast,
traditional CCBs (e.g. verapamil, dihydropyridines),
although blocking window ICaL to some extent, block
peak and window ICaL indiscriminately (i.e. with no pre-
ferential effect in the window voltage range). Inhibition
of normally activating (not re-activating) ICaL (i.e.
peaking at voltages largely positive to the window
region), depresses excitation–contraction coupling, and
thus limits therapeutic value, particularly in patients with
compromised cardiac function. Future studies of any
candidate window ICaL narrowing drug(s) should assess
their effects on all aspects of atrial excitation–contraction
coupling, and using a variety of EAD-promoting inter-
ventions. These could include, as studied in ventricle,
[Ca2+]i-overload from isoprenaline and/or BayK 8644
(January & Riddle, 1989; Zhao et al. 2012), as well as
oxidative stress, hypokalaemia or heart failure.
The present dynamic clamp study of ICaL, the first to
our knowledge in atrial cells, has identified a potentially
anti-arrhythmic (in isolated cells, at least) ion current
(electrical component) mechanism of action. If new
drugs could be developed (or existing ones identified
or modified) that preferentially target the ICaL window
region, by shifting voltage-dependent activation and/or
inactivation curves with the result of narrowing the
ICaL window, without substantially affecting [Ca2+]i and
thus excitation–contraction coupling, and with minimal
adverse effects, then these drugs could be much needed
candidates for testing for anti-AF action, in vitro and in
vivo.
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